OTCM
TRLHF
Market cap83kUSD
Mar 07, Last price
0.02USD
Name
Trellus Health PLC
Chart & performance
P/E
—
P/S
20.63
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
114k
+500.00%
Net income
-8m
L+22.76%
CFO
-7m
L+38.81%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Trellus Health plc delivers digital health management services for long-term illnesses, primarily serving businesses and insurance companies. The cornerstone of their offerings is TrellusElevate, a secure, proprietary technology platform compliant with HIPAA regulations. This system enables the remote coordination and provision of individualized healthcare via telemedicine. Patients utilizing the platform gain access to dedicated care teams, comprehensive educational materials, and remote monitoring tools. This service specifically addresses inflammatory bowel diseases (IBD), encompassing chronic and incurable conditions like Crohn's Disease and ulcerative colitis. Founded in 2020, Trellus Health plc is headquartered in White Plains, New York.
Key people
Kevin Murphy
Non-Executive Independent Chairman of the Board · since 2024
Joy Bessenger
Chief Financial Officer · since 2023
Marla Dubinsky
Chief Executive Officer, Executive Director · since 2022
Erik Lium
Non-Executive Director
Mike Salter
Non-Executive Director
Traci Entel
Senior Independent Non-Executive Director · since 2022
Brian Griffin
Non-Executive Independent Director · since 2024
Headquarters & legal address
201 TEMPLE CHAMBERS
3-7 TEMPLE AVENUE
LONDON, LND EC4Y 0DT
GB
3-7 TEMPLE AVENUE
LONDON, LND EC4Y 0DT
GB
Previous name
TRELLUS HEALTH LIMITED
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||